$214 Million is the total value of HealthInvest Partners AB's 18 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIK | Buy | ANIKA THERAPEUTICS INC | $21,928,000 | +51.7% | 490,331 | +29.5% | 10.27% | +50.9% |
| FEIC | Buy | FEI CO | $21,328,000 | +49.5% | 239,609 | +34.0% | 9.99% | +48.8% |
| LPNT | Sell | LIFEPOINT HEALTH INC | $19,004,000 | -30.7% | 274,430 | -26.5% | 8.90% | -31.0% |
| GNCIQ | Sell | GNC HLDGS INC | $18,636,000 | -26.8% | 586,955 | -28.5% | 8.73% | -27.2% |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $17,330,000 | +10.4% | 740,585 | +42.4% | 8.11% | +9.8% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $13,779,000 | -2.5% | 903,533 | -14.1% | 6.45% | -3.0% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $13,541,000 | -7.8% | 178,307 | -2.4% | 6.34% | -8.3% |
| TARO | New | TARO PHARMACEUTICAL INDS LTD | $13,466,000 | – | 94,005 | +100.0% | 6.30% | – |
| INCR | New | INC RESH HLDGS INCcl a | $13,363,000 | – | 324,270 | +100.0% | 6.26% | – |
| MRK | New | MERCK & CO INC NEW | $13,302,000 | – | 251,400 | +100.0% | 6.23% | – |
| ANTM | Sell | ANTHEM INC | $13,051,000 | -11.5% | 93,900 | -11.2% | 6.11% | -11.9% |
| GTS | Sell | TRIPLE-S MGMT CORPcl b | $12,525,000 | -13.7% | 503,826 | -17.0% | 5.86% | -14.1% |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $9,731,000 | – | 370,000 | +100.0% | 4.56% | – |
| SSRG | Buy | SYMMETRY SURGICAL INC | $3,120,000 | +13.6% | 316,427 | +6.0% | 1.46% | +13.1% |
| OSUR | New | ORASURE TECHNOLOGIES INC | $2,934,000 | – | 405,771 | +100.0% | 1.37% | – |
| DEPO | New | DEPOMED INC | $2,786,000 | – | 200,000 | +100.0% | 1.30% | – |
| SCLN | New | SCICLONE PHARMACEUTICALS INC | $2,599,000 | – | 236,288 | +100.0% | 1.22% | – |
| ICCC | Buy | IMMUCELL CORP | $1,153,000 | +22.0% | 168,323 | +34.3% | 0.54% | +21.3% |
| VAR | Exit | VARIAN MED SYS INC | $0 | – | -184,000 | -100.0% | -7.00% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -248,934 | -100.0% | -7.22% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -229,300 | -100.0% | -10.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-04-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.